Literature DB >> 8473903

Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.

M Morissette1, T Di Paolo.   

Abstract

Dopamine released from brain nerve terminals is mainly removed from the synaptic cleft by an uptake mechanism. Despite their functional importance, modulation of the dopamine uptake sites is still not well known. Steroid hormones were shown to modulate brain dopamine transmission. The aim of this study was thus to investigate in ovariectomized rats the effects of 17 beta-estradiol and progesterone treatments on brain dopamine uptake sites. Treatments consisted of 17 beta-estradiol (10 micrograms/0.2 ml), progesterone (0.72 mg/0.2 ml), 17 beta-estradiol + progesterone, or the vehicle (0.3% gelatin in saline solution) twice daily for 2 weeks. The steroid treatments left the affinity of [3H]GBR 12935 binding to striatal homogenates unchanged (ovariectomized rats, 0.823 +/- 0.028 nM), whereas the density was increased by these steroids alone or in combination to a similar extent of 16-23%. Chronic treatment of ovariectomized rats with 17 beta-estradiol, progesterone, or their combination increased to the same extent and uniformly [3H]-GBR 12935 binding in the striatum as measured by autoradiography; the increase was similar in the substantia nigra pars compacta, whereas no steroid effect was observed in the nucleus accumbens and in the substantia nigra pars reticulata. In summary, chronic exposure to 17 beta-estradiol and/or progesterone increased dopamine uptake site density in the nigrostriatal dopaminergic system, whereas the nucleus accumbens and the substantia nigra pars reticulata were unaffected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473903     DOI: 10.1111/j.1471-4159.1993.tb13415.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  28 in total

1.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration.

Authors:  Hongyan Yang; Wei Zhao; Ming Hu; Jill B Becker
Journal:  Behav Brain Res       Date:  2007-07-12       Impact factor: 3.332

Review 3.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

4.  Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Menopause       Date:  2012-07       Impact factor: 2.953

Review 5.  The Role of Estrogen in Brain and Cognitive Aging.

Authors:  Jason K Russell; Carrie K Jones; Paul A Newhouse
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

6.  Effects of sex and estrogen on behavioral sensitization to cocaine in rats.

Authors:  Ming Hu; Jill B Becker
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 7.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

8.  The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats.

Authors:  Nioka C Chisholm; Alexandria R Packard; Wendy A Koss; Janice M Juraska
Journal:  Endocrinology       Date:  2012-08-17       Impact factor: 4.736

9.  Impact of dietary genistein and aging on executive function in rats.

Authors:  Steven L Neese; Victor C Wang; Daniel R Doerge; Kellie A Woodling; Juan E Andrade; William G Helferich; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2009-11-27       Impact factor: 3.763

10.  Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux.

Authors:  Rebecca A Alyea; Cheryl S Watson
Journal:  BMC Neurosci       Date:  2009-06-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.